Teva Prepares To Fight Appeal After US Narcan Victory
Four Patents For Naloxone Spray Invalidated By District Court, But Appeal Looms
Teva has won a US district court victory invalidating four patents protecting the Narcan naloxone nasal spray. However, despite holding FDA approval for a generic, the Israeli firm believes the battle is far from over.
